These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 19416991

  • 1. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U, Burkard N, Vogt C, Thoma A, Frantz S, Ertl G, Ritter O, Bonz A.
    Cardiovasc Res; 2009 Jul 15; 83(2):285-93. PubMed ID: 19416991
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S, Christoffersen C, Axelsen LN, Montecucco F, Rochemont V, Frias MA, Mach F, James RW, Naus CC, Chanson M, Lampe PD, Nielsen MS, Nielsen LB, Kwak BR.
    Cardiovasc Res; 2016 Mar 01; 109(3):385-96. PubMed ID: 26762268
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ, Hla T, Rosen H.
    J Biol Chem; 2007 Mar 09; 282(10):7254-64. PubMed ID: 17218309
    [Abstract] [Full Text] [Related]

  • 8. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
    Sobel K, Menyhart K, Killer N, Renault B, Bauer Y, Studer R, Steiner B, Bolli MH, Nayler O, Gatfield J.
    J Biol Chem; 2013 May 24; 288(21):14839-51. PubMed ID: 23589284
    [Abstract] [Full Text] [Related]

  • 9. P2X7 receptor agonists pre- and postcondition the heart against ischemia-reperfusion injury by opening pannexin-1/P2X₇ channels.
    Vessey DA, Li L, Kelley M.
    Am J Physiol Heart Circ Physiol; 2011 Sep 24; 301(3):H881-7. PubMed ID: 21685263
    [Abstract] [Full Text] [Related]

  • 10. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ, Frias M, Lacerda L, Opie LH, Lecour S.
    Cardiovasc Drugs Ther; 2012 Jun 24; 26(3):227-37. PubMed ID: 22392184
    [Abstract] [Full Text] [Related]

  • 11. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E, Sanna MG, Gonzalez-Cabrera PJ, Thangada S, Tigyi G, Osborne DA, Hla T, Parrill AL, Rosen H.
    Chem Biol; 2005 Jun 24; 12(6):703-15. PubMed ID: 15975516
    [Abstract] [Full Text] [Related]

  • 12. FTY720 postconditions isolated perfused heart by a mechanism independent of sphingosine kinase 2 and different from S1P or ischemic postconditioning.
    Vessey DA, Li L, Imhof I, Honbo N, Karliner JS.
    Med Sci Monit Basic Res; 2013 Apr 09; 19():126-32. PubMed ID: 23567658
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection.
    Karliner JS.
    J Cardiovasc Pharmacol; 2009 Mar 09; 53(3):189-97. PubMed ID: 19247197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R, Trovato L, Gallo MP, Destefanis S, Settanni F, Scarlatti F, Brero A, Ramella R, Volante M, Isgaard J, Levi R, Papotti M, Alloatti G, Ghigo E.
    Cardiovasc Res; 2009 Jul 15; 83(2):303-12. PubMed ID: 19293247
    [Abstract] [Full Text] [Related]

  • 17. New players on the center stage: sphingosine 1-phosphate and its receptors as drug targets.
    Huwiler A, Pfeilschifter J.
    Biochem Pharmacol; 2008 May 15; 75(10):1893-900. PubMed ID: 18321471
    [Abstract] [Full Text] [Related]

  • 18. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylated FTY720 promotes astrocyte migration through sphingosine-1-phosphate receptors.
    Mullershausen F, Craveiro LM, Shin Y, Cortes-Cros M, Bassilana F, Osinde M, Wishart WL, Guerini D, Thallmair M, Schwab ME, Sivasankaran R, Seuwen K, Dev KK.
    J Neurochem; 2007 Aug 13; 102(4):1151-61. PubMed ID: 17488279
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of sphingosine-1-phosphate induced cardioprotection against I/R injury in diabetic rat heart: Possible involvement of glycogen synthase kinase 3β and mitochondrial permeability transition pore.
    Rana A, Sharma S.
    Clin Exp Pharmacol Physiol; 2016 Feb 13; 43(2):166-73. PubMed ID: 26582369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.